1Pastorio U, McCormack PM. Lung metastases://Abeloff JO, Armitager JO, Lichter AS, et al. Clinical oncology. Volume 1.2nd ed. Sigapore: Harcourt Asia, 2000: 872-885.
2Pass HI, Doningdon JS. Metastatic cancer to the lung. //Devita VT, Hellman S, Rosenberg SA. Cancer: principles and practice of oncology. 5nd ed. Philadelphia: Lippincott-Raven Publishers, 1997: 2536-2551.
3Dranoff G, Jaffee E, Lazenby A, et al. Vaccination with irradiated tumor ceils engineered to secrete routine granulocyte-macrnphage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Pro Natl Acd Scin U S A, 1993, 90:3539-3543.
4Anderson PM, Markovic SN, Sloan JA, et al. Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases. Clin Cancer Res, 1999, 5: 2316-2323.
5Tatsumara T, Kogama S, Taujimolo M. Further study of nebulization chemotherapy, a new chemotherapeutic method in the treatment of lung carcinoma: fundamental and clinical. BrJ Cancer, 1993, 68: 1146-1149.
6Stanley E, Lieschke GJ, Grai D. et al. Granulocyte/macrphage colony-stimulating factor-deficient mice show no major perturbation of hematopoiesis but develop a characteristic pulmonary, pathology. Proc Natl Acd Sci U S A, 1994, 94: 5592-5596.
7Markovics SN, Suman V J, Nevala WK, et al. A dose-escalation study of aerosolized sargramostimin in the treatment of metastatic melanoma:an NCCTG studv. Am J Clin Oncol. 2008.31: 573-579.
